Stonepine Capital Management, LLC

Position in INDV — Indivior Pharmaceuticals, Inc.

CIK 1440771 BEND, OR

Back to INDV Full portfolio

Position in INDV

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$4,103,000

New position

Shares Held

100,000

first reported quarter

Ownership

0.085%

of shares outstanding

% of Portfolio

3.12%

of 13F equity value

Holder Rank

#97

of 337 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Stonepine Capital Management, LLC holds $17,591,704 across 4 Drug Manufacturers - Specialty & Generic names. INDV ranks #2 (23.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EOLS	Evolus, Inc.	1,590,162	$11,035,724
2	INDV	Indivior Pharmaceuticals, Inc. This page	100,000	$4,103,000
3	AYTU	Aytu Biopharma, Inc	912,921	$1,962,780
4	BIOA	BioAge Labs, Inc.	20,000	$490,200

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,103,000	100,000	—	Shares	Sole	2026-08-17
No filing history on record for this holder in this stock.

Stonepine Capital Management, LLC

Position in INDV

Position in Drug Manufacturers - Specialty & Generic

All Filings in INDV